EUVIMEDEUVIMED entdecken
Crossref

Low-Dose Aspirin during Pregnancy and Postpartum Bleeding

Kelsey J White, Moeun Son, Lisbet S Lundsberg, Jennifer F Culhane, Caitlin Partridge, Uma M Reddy, Audrey A Merriam

American Journal of Perinatology · 01.10.2023 · 40 (13) · 1390-1397

DOI: 10.1055/a-2096-5199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.10.2023. Verfasst von Kelsey J White und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: Postpartum Hemorrhage. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to investigate whether aspirin 81 mg daily for preeclampsia prevention is associated with increased risk of postpartum blood loss at the time of delivery. Study Design This is a retrospective cohort study performed at a tertiary hospital from January 2018 to April 2021. Data were extracted from the electronic medical record. Patients prescribed low-dose aspirin (LDA) were compared with patients who were not. The primary outcome was a composite of postpartum blood loss, defined as: estimated blood loss (EBL) >1,000 mL, documentation of International Classification of Diseases-9/-10 codes for postpartum hemorrhage (PPH), or red blood cell (RBC) transfusion. Bivariate analysis, and unadjusted and adjusted logistic regression modeling were performed.

Results

Among 16,980 deliveries, 1,922 (11.3%) were prescribed LDA. Patients prescribed LDA were more likely to be >35 years old, nulliparous, obese, taking other anticoagulants, or have diagnoses of diabetes, systemic lupus erythematosus, fibroids, or hypertensive disease of pregnancy. After adjusting for potential confounders, the significant association between LDA use and the composite did not persist (adjusted odds ratio [aOR]: 1.1, 95% confidence interval [CI]: 1.0–1.3) nor did the association between EBL > 1,000 mL (aOR: 1.0, 95% CI: 0.9–1.3) and RBC transfusion (aOR: 1.3, 95% CI: 0.9–1.7). The association between LDA and PPH remained significant (aOR: 1.3, 95% CI: 1.1–1.6). Patients who discontinued LDA

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postpartum HemorrhagePregnancyFemaleHumansAdultRetrospective StudiesAspirinAnticoagulantsPostpartum Period

Substanzen

AspirinAnticoagulants

Autor:innen und Institutionen

  • Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut.
  • Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York.

Zitieren

APA

White, K. J., Son, M., Lundsberg, L. S., Culhane, J. F., Partridge, C., Reddy, U. M., & Merriam, A. A. (2023). Low-Dose Aspirin during Pregnancy and Postpartum Bleeding. American Journal of Perinatology, 40(13), 1390-1397. https://doi.org/10.1055/a-2096-5199

Vancouver

White KJ, Son M, Lundsberg LS, Culhane JF, Partridge C, Reddy UM, et al. Low-Dose Aspirin during Pregnancy and Postpartum Bleeding. American Journal of Perinatology. 2023;40(13):1390-1397. doi:10.1055/a-2096-5199

BibTeX
@article{White2023,
  author = {White, Kelsey J and Son, Moeun and Lundsberg, Lisbet S and Culhane, Jennifer F and Partridge, Caitlin and Reddy, Uma M and Merriam, Audrey A},
  title = {Low-Dose Aspirin during Pregnancy and Postpartum Bleeding},
  journal = {American Journal of Perinatology},
  year = {2023},
  volume = {40},
  number = {13},
  pages = {1390--1397},
  doi = {10.1055/a-2096-5199}
}
Kostenlos starten →